LEO-Pharma and Hanmi Pharmaceutical have made the co-promotion contract for the skin problem market

Published: 2014-12-22 10:50:45

Updated: 2014-12-22 10:50:45

LEO Pharma (president Sang-eun Joo) and Hanmi Pharmaceutical (president Kwan-soon Lee) will co-promote to improve accessibilityand quality of skin disease patients’ lives.

Participated with Byron Yin, Regional Vice President of LEO Pharma Asia, the two companies has made a strategic sale contract on the 18^th to perform co-marketing for the inflammatory skin treatment ‘Xamiol Gel’ and ‘Daivobet...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.